Shares of Edwards Lifesciences Corp. /zigman2/quotes/205745196/composite EW +0.52% slid 1.27% to $119.35 Monday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index /zigman2/quotes/210599714/realtime SPX +0.37% rising 0.23% to 4,468.73 and the Dow Jones Industrial Average /zigman2/quotes/210598065/realtime DJIA +0.43% rising 0.76% to 34,869.63. This was the stock's third consecutive day of losses. Edwards Lifesciences Corp. closed $3.92 below its 52-week high ($123.27), which the company reached on September 8th.
The stock demonstrated a mixed performance when compared to some of its competitors Monday, as Medtronic PLC /zigman2/quotes/206816578/composite MDT -0.34% fell 0.84% to $130.04, Boston Scientific Corp. /zigman2/quotes/203726728/composite BSX +0.77% fell 0.56% to $44.21, and ICU Medical Inc. /zigman2/quotes/208026181/composite ICUI +1.20% fell 1.63% to $240.07. Trading volume (1.5 M) remained 539,240 below its 50-day average volume of 2.1 M.